Watch Demo

Sweden Cardiovascular Drug Industry Outlook 2022 - 2026

See how Sweden Cardiovascular Drug performed compared to key markets such as Germany, Italy and Canada.

Key Market Indicators

Swedish Beta Blocking Medicine sales are projected to drop 0.7% year on year to reach $50 million by 2026. The market has grown 3.1% year on year since 2005. In 2021, Sweden was ranked 9th with $53.57 million in sales. Greece overtook Sweden to take the lead with $53.57 million. Italy, Canada and Australia followed as the second, third and fourth largest markets, respectively.

Marketing Banner

Sweden Cardiovascular Drug Market Data and Forecasts

How much will Sweden Cardiovascular Drug Market grow to 2026?

Forecast: Antihypertensive Medicine Sales in Sweden
Forecast: Cardiovascular System Medicine Sales in Sweden
Forecast: Antihypertensive Medicine Sales in Sweden
Forecast: Renin-Angiotensin System Medicine Sales in Sweden
Forecast: Renin-Angiotensin System Medicine Sales in Sweden
More in Cardiovascular Drug Industry for 2028

Improve your Knowledge with the latest Indicators and Trends